Back
Viking Therapeutics Stock Price Chart
Sponsored
VKTX
Sponsored
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
VKTX
Viking Therapeutics
Last Price:
64.40
Seasonality Move:
34.33%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.29 | Buy |
20-day SMA: | 63.32 | Buy |
50-day SMA: | 60.76 | Buy |
200-day SMA: | 55.03 | Buy |
8-day EMA: | 63.88 | Buy |
20-day EMA: | 63.16 | Buy |
50-day EMA: | 61.34 | Buy |
200-day EMA: | 52.6 | Buy |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.97 | Buy |
Relative Strength Index (14 RSI): | 54.51 | Buy |
Chaikin Money Flow: | 1135470 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.05 - 66.47) | Buy |
Bollinger Bands (100): | (52.64 - 64.98) | Buy |
Viking Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 64.96 while VKTX 8-day simple moving average is 63.29, which is a Buy signal.
- The stock price of VKTX is 64.96 while Viking Therapeutics 20-day SMA is 63.32, which makes it a Buy.
- Viking Therapeutics 50-day simple moving average is 60.76 while VKTX share price is 64.96, making it a Buy technically.
- VKTX stock price is 64.96 and Viking Therapeutics 200-day simple moving average is 55.03, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Buy
The current Viking Therapeutics [VKTX] share price is $64.96. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Viking Therapeutics Stock Info
Market Cap:
7.2B
Price in USD:
64.96
Share Volume:
2.1M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
8.28
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 64.96 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is not overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 64.96 while VKTX 8-day exponential moving average is 63.88, which is a Buy signal.
- The stock price of VKTX is 64.96 while Viking Therapeutics 20-day EMA is 63.16, which makes it a Buy.
- Viking Therapeutics 50-day exponential moving average is 61.34 while VKTX share price is 64.96, making it a Buy technically.
- VKTX stock price is 64.96 and Viking Therapeutics 200-day simple moving average is 52.60, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is 0.97, suggesting Viking Therapeutics is a Buy
- Viking Therapeutics Relative Strength Index (RSI) is 54.51, which suggest Viking Therapeutics is overbought
- The Bollinger Bands (25) for Viking Therapeutics is (58.05 - 66.47), which suggest Viking Therapeutics is a Buy
- The Bollinger Bands (100) for Viking Therapeutics is (52.64 - 64.98), which suggest Viking Therapeutics is a Buy
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.